logo
logo
Sign in

West Nile Virus Market Growth Accelerated by Increasing Prevalence of West Nile Virus

avatar
Pooja salve
West Nile Virus Market  Growth Accelerated by Increasing Prevalence of West Nile Virus

West Nile Virus (WNV) is a mosquito-borne flavivirus that infects humans, birds, horse and other mammals. The virus commonly causes West Nile fever, a mild flu-like illness. However, severe manifestation includes encephalitis, meningitis or even death especially in elderly people and immunocompromised patients. Rising occurrences of WNV infection globally has boosted the demand for effective prevention and treatment measures.

The global West Nile Virus Market is estimated to be valued at US$ 634.8 Mn in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing prevalence of WNV disease is a major factor fueling the demand for effective prevention and treatment options. As per CDC, in 2020 over 2,500 cases of WNV disease in humans were reported to CDC, including 138 deaths. Moreover, lack of an approved vaccine for human use presents lucrative opportunities for drug developers. Several drugs and vaccines are under development and clinical trials which once approved can provide major breakthrough. For instance, VLA1553 and VLA1601 vaccines developed by Valneva SE are under phase III and II clinical trials respectively. Rising R&D investments by pharmaceutical companies to develop advanced treatment options will further drive the market growth over the forecast period.

Segment Analysis

The global west nile virus market can be segmented by product type, and end-use. Based on product type, the diagnostics segment dominated the market with more than 50% share in 2023. This is due to increasing awareness regarding early diagnosis as it can improve treatment outcomes. Under diagnostics, blood screening plays an important role as it helps in detecting infection at early stages. Based on end-use, the hospitals segment accounted for the largest share owing to the availability of advanced healthcare facilities and skilled doctors for diagnosis and treatment under one roof.

Key Takeaways

Global West Nile Virus Market Size is expected to witness high growth. Regional analysis shows that North America accounted for around 35% share of the global west nile virus market in 2023.

Higher incidence of west nile virus in the US and Canada combined with rise in mosquito-borne diseases are major factors responsible for market dominance in the region. Europe is anticipated to be the fastest-growing regional market between 2023-2030 owing to increasing investment and funding by regional governments for infectious disease prevention and control.

Key players operating in the west nile virus market are Sanofi, Pfizer, GlaxoSmithKline, Merck, AstraZeneca, Johnson & Johnson, F. Hoffmann-La Roche, Novartis, Cipla, and Gilead Sciences. Sanofi's Flavivir is a popular vaccine available for west nile virus prevention. Pfizer's Ixiaro is another important preventive vaccine prescribed by doctors globally.

Get More Insights on this Topic- https://www.dailyprbulletin.com/west-nile-virus-market-outlook-and-value-insights/

collect
0
avatar
Pooja salve
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more